Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 13th December 2016
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Independent Vetcare acquired by EQT
hand shaking
The parties involved have decided not to disclose the value of the transaction.
Agreement signed to take over as principal investor

Scandinavian investment firm EQT has signed an agreement to acquire Independent Vetcare (IVC) from Summit Partners.

The parties involved have decided not to disclose the value of the transaction, which is expected to close in early 2017.

IVC was founded in 2011 through the merge of three veterinary groups. Reportedly the third largest veterinary services provider in the UK, it has just under 300 sites and employs around 2,700 people.

Global growth equity company Summit Partners has been its principal investor since July 2014. But according to David Hiller, IVC's CEO, the business began looking for a new partner earlier this autumn to continue its development.

EQT already owns Evidensia, one of the leading veterinary groups in Europe.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.